We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 1CLX market cap is 15.15B. The company's latest EPS is USD 2.2729 and P/E is 61.16.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.72B | 7.34B | 7.11B | 7.39B | 7.09B |
| Operating Income | 1.28B | 986M | 725M | 330M | 702M |
| Net Income | 939M | 710M | 462M | 149M | 280M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.21B | 6.33B | 6.16B | 5.95B | 5.75B |
| Total Liabilities | 5.31B | 5.74B | 5.43B | 5.56B | 5.26B |
| Total Equity | 908M | 592M | 729M | 388M | 492M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.55B | 1.28B | 786M | 1.16B | 695M |
| Investing | -252M | -452M | -229M | -223M | -175M |
| Financing | -523M | -1.39B | -689M | -753M | -655M |
| Market Cap | 15.15B |
| Price to Earnings Ratio | 61.16 |
| Price to Sales Ratio | 2.41 |
| Price to Cash Ratio | 174.75 |
| Price to Book Ratio | 34.81 |
| Dividend Yield | 4.51% |
| Shares Outstanding | 123.19M |
| Average Volume (1 week) | 135 |
| Average Volume (1 Month) | 135 |
| 52 Week Change | -6.76% |
| 52 Week High | 155.46 |
| 52 Week Low | 118.28 |
| Spread (Intraday) | 3 (2.42%) |
| Company Name | Clorox Co |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.thecloroxcompany.com |
| Industry | consumer nondurables diverse (C2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
